Jon Cuthbert

Morgan Stanley (NYSE:MS) reported record Q2 2026 net revenue of $21.3 billion and diluted EPS of $3.46 as its major business divisions expanded.

Fractyl Health (NASDAQ:GUTS) reported one-year REMAIN-1 data showing 7.8% weight regain with Revita versus 13% with sham in 45 participants.

ARC Resources shareholders approved its approximately C$22 billion acquisition by Shell (NYSE:SHEL), with 99.54% backing the arrangement.

Cardano (CRYPTO:ADA) gained 3.5% after breaking above a key resistance level, with large investors increasing their holdings as buying activity strengthened.

Dexus (ASX:DXS) has secured a three-day appeal hearing beginning Oct. 20 regarding its ongoing APAC infrastructure dispute.

Kingsgate Consolidated (ASX:KCN) restarted its Plant 1 circuit, lifting total capacity over 4 million tonnes per annum.

US Senator Thom Tillis has proposed combining stablecoin legislation with the CLARITY Act as Congress considers new crypto regulations.

Merck (NYSE:MRK) said its 299-patient KEYNOTE-C93 trial met its PFS endpoint for Keytruda monotherapy versus chemotherapy in dMMR endometrial cancer.

Coinbase said artificial intelligence now generates more than 95% of the code written across the company.

Alfabs Australia (ASX:AAL) has reduced its net debt to $36.6 million and generated positive free cash flow in its Q4 FY26 operational update.